Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing
Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47